.Chris Edlin
Director at Pharmaceutical Manufacturing Technology Centre
- Pharmaceutical Manufacturing Technology Centre
University of Limerick,
Castletroy,
Limerick,
Ireland - Telephone: +353 61 202293
- Email: chris.edlin@ul.ie
links
Summary
Experienced Research Director, fundraiser and CSO/CEO who has held leadership positions with Sanofi-Aventis, GSK, Roche, Medical Research Council Technology, iThemba Pharmaceuticals and PMTC.
Key Achievements:
• Grew start up from 3 to >25 FTEs
• Established and grew, from grass roots, an international chemistry CRO business with $MM turnover
• Delivered multiple clinical candidates across a variety of therapeutic areas
• Identified, built and funded multiple $MM international projects between Industry, Academia and PPPs
Strong communication, marketing, management and strategic thinking skills. Extensive and robust experience in forming networks and relationships and working across diverse cultures, levels and backgrounds.
Specialties: Production and delivery of business plans, Creating laboratory infrastructure, Hiring senior staff, Board level communication and facilitation, Team building, Innovation optimisation, Synthetic chemistry problem solving, Managing drug discovery and contract research projects, Project Management, Matrix leadership, Stake holder management, Strategy implementation, Neglected disease research, Technology assessment and delivery.
Key Achievements:
• Grew start up from 3 to >25 FTEs
• Established and grew, from grass roots, an international chemistry CRO business with $MM turnover
• Delivered multiple clinical candidates across a variety of therapeutic areas
• Identified, built and funded multiple $MM international projects between Industry, Academia and PPPs
Strong communication, marketing, management and strategic thinking skills. Extensive and robust experience in forming networks and relationships and working across diverse cultures, levels and backgrounds.
Specialties: Production and delivery of business plans, Creating laboratory infrastructure, Hiring senior staff, Board level communication and facilitation, Team building, Innovation optimisation, Synthetic chemistry problem solving, Managing drug discovery and contract research projects, Project Management, Matrix leadership, Stake holder management, Strategy implementation, Neglected disease research, Technology assessment and delivery.
New appointment to lead on partnerships between medical research and industry
Chris Edlin joins as Head of Enterprise Research Partnerships for the College of Medicine, Biological Sciences & Psychology
Chris has joined the University of Leicester as Head of Enterprise Research Partnerships for The College of Medicine, Biological Sciences & Psychology, based in the Enterprise and Business Development Office. He will primarily be responsible for developing new and expanding existing relationships between College research groups and industrial research partners and will take a leading role in assessing the industrial partnership potential of current research strengths across the College and accelerate the development of these enterprise opportunities.
Chris has previously held positions as Chief Scientific Officer at iThemba Pharmaceuticals (Johannesburg, South Africa), Group Leader (Medicinal Chemistry) with the Medical Research Council Technology, Team Leader (Medicinal Chemistry) with GSK and Roche Pharmaceuticals and Senior Medicinal Chemist with Sanofi Aventis.
Chris’s background in drug discovery has given him the opportunity to contribute to a broad range of activities from lead generation to the identification of clinical candidates across a number of different therapeutic areas including inflammation, respiratory diseases, HIV and infectious diseases working directly on multiple different target types (e.g. GPCRs, kinases and enzymes). Furthermore, he has considerable experience in managing drug discovery and contract research projects, matrix leadership, technology assessment and implementation, writing business plans, creating laboratory infrastructure, board level communication, intellectual property assessment and due diligence
He holds a first class degree in Chemistry and a PhD in Organic Chemistry, both awarded by the University of Durham, and is the author of over 40 scientific publications and patents. He was elected as a Fellow of the Royal Society of Chemistry in 2012.\
Experience
Director
Pharmaceutical Manufacturing Technology Centre
Director of a new Centre in Pharmaceutical Manufacturing hosted at the University of Limerick (UL), with an ambitious research and development program. With seed funding from Enterprise Ireland, IDA and an industrial consortium of Irish and multinational companies the Centre will conduct innovative, high quality research in pharmaceutical manufacturing that has direct relevance to industry.
I am responsible for the overall direction, financial control (full P&L) and management of the research in the Centre. I am also responsible for delivering a five-year business plan with defined success metrics and research outcomes that are consistent with this business plan. Critical to the role is taking a leadership role in fostering pharmaceutical manufacturing research at a national and international level, in conjunction with industrial and academic partners, and funding agencies.
I am responsible for the overall direction, financial control (full P&L) and management of the research in the Centre. I am also responsible for delivering a five-year business plan with defined success metrics and research outcomes that are consistent with this business plan. Critical to the role is taking a leadership role in fostering pharmaceutical manufacturing research at a national and international level, in conjunction with industrial and academic partners, and funding agencies.
The Pharmaceutical Manufacturing Technology Centre (PMTC) is hosted by the University of Limerick with core funding of €1M per annum from the Irish government (Enterprise Ireland and the IDA Ireland). Income is supplemented with co-funding from industry and other public sources.
PMTC, established in December 2013, is led by an industry steering board with an active research program driven by its industry members. Companies access PMTC to create projects and execute world-beating industry-relevant research in advanced technology solutions to address contemporary manufacturing issues.
Head of Enterprise Research Partnerships
University of Leicester
iThemba Pharmaceuticals
Responsible for project identification and funding in neglected diseases with a primary focus on TB discovery and HIV process innovation. Multiple international collaborative projects initiated and transitioned into H2L and LO. Most senior company officer with full P&L responsibility. Also responsible for fund raising, board and scientific advisory committee communication and company infrastructure and strategy.
Built and grew ($$MM turnover) a contract research division offering H2L and LO chemistry services from South Africa to a range of local and international clients
Built and grew ($$MM turnover) a contract research division offering H2L and LO chemistry services from South Africa to a range of local and international clients
Senior Medicinal Chemist
sanofi-aventis
Education
Durham University
BSc, Chemistry
First class honours
Awarded ICI scholarship for academic achievement
Awarded ICI scholarship for academic achievement
Honors & Awards
Fellow of the Royal Society of Chemistry
Royal Society of Chemistry
Associated Professor of Chemistry at the University of the Free State
University of the Free State
African Network for Drug Discovery and Diagnostic Innovation Centre of Excellence
World Health Organisation (via ANDI)
UL Hosts New €5M Pharmaceutical Manufacturing Technology Centre
Ul Hosts New €5m Pharmaceutical Manufacturing Technology Centre
The Minister for Skills, Research and Innovation, Damien English TD, recently launched the Pharmaceutical Manufacturing Technology Centre (PMTC) which will be headquartered at the University of Limerick. The State, through the Department of Jobs, Enterprise & Innovation, is investing €5M over the next 5 years in this industry-focussed Centre which will deliver advanced technology solutions to contemporary manufacturing issues currently challenging the Irish pharmaceutical sector. PMTC is the latest of 15 state-supported Technology Centres established jointly by Enterprise Ireland and IDA Ireland. The Centre brings together 24 industry partners and 9 Higher Education Institutes who will deliver the research.
The aim of PMTC is to make Ireland the global hub of pharmaceutical process innovation and manufacturing and ultimately support an industry which directly employs over 25,000 people. Manufacturing cost competitiveness and patent expiry are among the two most critical issues which threaten the future of this industry which contributes over €40BN in Irish exports per annum. The industry consortium currently comprises a mix of indigenous multinational pharmaceutical companies and SME’s including: Alkermes, Allergan Pharmaceutical, Applied Process Consulting, Astellas, Bristol-Myers Squibb Swords, Crest Solutions, Eli Lilly, Gilead, GSK, Helsinn Birex, Innopharma Labs, Janssen, Label Art, Leo Pharma, Merck Sharp Dohme, Pfizer, Process Analytics, Roche, Servier, Sigmoid Pharma, Takeda Pharmaceuticals, Techno-Path, Teva Pharmaceuticals and TopChem Pharma.
Pictured above are: Dr Chris Edlin, Director, PMTC, Minister Damien English, Dr Mary Shire, Vice President Research, UL, Professor Gavin Walker, Bernal Chair of Pharmaceutical Powder Engineering, UL and PMTC Research Team
- 2014
- October 2014
PMTC launch Good Cleaning Validation document at inaugural Knowledge Day event
Dr. Chris Edlin and Prof. Gavin Walker pictured at the launch of the Good Cleaning Validation document. (Photo: Alan Place FusionShooters)
Responding directly to key areas of concern and interest relating to cleaning validation identified by attendees at their 2014 cleaning workshop PMTC commissioned The Compliance Group to deliver a ‘good cleaning validation practice (GCVP)’ document. Based on a review of current guidelines and input from HPRA, PharmaChemical Ireland, cleaning validation sub-teams and other Industry members t is now available to download on www.pmtc.ie. A companion app is in preparation and will be available in the near future.
The document was launched at the very successful inaugural PMTC Knowledge Day event held in the Kemmy Business School on 28th August 2015. The event showcased the state funded, industry informed research programs in the centre. It also provided a unique forum for networking with industrial and
academic colleagues working at the cutting edge of pharmaceutical innovation in Ireland. Presentations, by PMTC researchers and industrialists covered areas including powder modelling for tablet processing and 3D printing and advanced manufacturing technologies. We were pleased to
host key note speakers including John Lynch (Director of Compliance HPRA), Martin Wallace (GSK), Stan O’Neill (The Compliance Group) and Charles Gordon (Britest). Poster sessions, highlighting recent research developments, also took place alongside vendor and partner companies exhibits. Companies and technology centres represented included Zenith Ireland, STERIS, InnopharmaLabs, Britest, BARD (UCC), Antech, Topchem Pharma, ALMAC, SSPC and DPTC.
PMTC continues to strategically focus on developing advanced technology solutions for challenges facing all stages of pharmaceutical manufacturing.
.
.
No comments:
Post a Comment